Stock Information
Grail Inc (GRAL)
Ticker Symbol: GRAL
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,447.92 mil
Piotroski score: 3
PE Ratio: N/A
EPS (TTM): -9.75
Revenue (TTM): $3.83 M
Dividend Yield: N/A
ROE: -15.88%
Latest News
-
GRAIL: AdCom's Vote Of Confidence Is Significant
Mon, Sep 28, 2026 10:51 AM
-
Canaccord Genuity Maintains Buy on GRAIL, Raises Price Target to $150
Mon, Sep 28, 2026 8:40 AM
-
Micron, Nike To Headline Earnings Next Week; GDP Numbers Awaited
Sat, Sep 26, 2026 11:00 AM
-
Here's Why Grail Stock Surged 55% This Week
Fri, Sep 25, 2026 9:25 AM
-
Mizuho Maintains Neutral on GRAIL, Raises Price Target to $100
Fri, Sep 25, 2026 8:19 AM
-
MRNA On Track To Be September's No. 2 S&P 500 Stock — But These 5 Smaller Health Care Names Did Even Better
Fri, Sep 25, 2026 3:23 AM
-
GRAIL (GRAL) Wins FDA Panel Backing, Is It Now Overvalued?
Thu, Sep 24, 2026 8:17 PM
-
Grail Surges After FDA Advisors Back Its Cancer-Finding Blood Test
Thu, Sep 24, 2026 8:13 PM
-
FDA Panel Endorses GRAIL Galleri Cancer Screening Tool
Thu, Sep 24, 2026 1:27 PM
-
Dow Jones Futures Fall As Treasury Yields, Oil Prices Keep Rising. Meta, Everpure, Grail Are Early Movers.
Thu, Sep 24, 2026 12:04 PM
Key Financials
Financial data not available